Impact of lymphopenia on COVID-19 infection severity
Joint Authors
Tariq, Ali Ayyad
Hamid, Naqa Majid
Abd al-Shahid, Tabarak Salim
Source
Issue
Vol. 19, Issue 1 (31 Mar. 2022), pp.99-101, 3 p.
Publisher
University of Babylon College of Medicine
Publication Date
2022-03-31
Country of Publication
Iraq
No. of Pages
3
Main Subjects
Topics
Abstract EN
Coronavirus disease-2019 (COVID-19) is an infectious disease caused by a new Coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-COV-2).
world health organization (WHO) first learned of this new virus on December 31, 2019, following a report of a cluster of cases of “viral pneumonia” in Wuhan, people's republic of china.
WHO declared the outbreak a public health emergency of international concern on January 30, 2020, and a pandemic on march 11, 2020.
globally according to WHO data, as of September 9, 2021 there were 4, 592, 934 deaths occurred due to this disease.
American Psychological Association (APA)
Tariq, Ali Ayyad& Hamid, Naqa Majid& Abd al-Shahid, Tabarak Salim. 2022. Impact of lymphopenia on COVID-19 infection severity. Medical Journal of Babylon،Vol. 19, no. 1, pp.99-101.
https://search.emarefa.net/detail/BIM-1339246
Modern Language Association (MLA)
Tariq, Ali Ayyad…[et al.]. Impact of lymphopenia on COVID-19 infection severity. Medical Journal of Babylon Vol. 19, no. 1 (Jan. / Mar. 2022), pp.99-101.
https://search.emarefa.net/detail/BIM-1339246
American Medical Association (AMA)
Tariq, Ali Ayyad& Hamid, Naqa Majid& Abd al-Shahid, Tabarak Salim. Impact of lymphopenia on COVID-19 infection severity. Medical Journal of Babylon. 2022. Vol. 19, no. 1, pp.99-101.
https://search.emarefa.net/detail/BIM-1339246
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 100-101
Record ID
BIM-1339246
